All Stories

  1. Discovery of allosteric mechanism of beta-lactam binding in non-classical transpeptidases
  2. Discovery of most conserved epitope regions in COVID-19 virus from across the globe.
  3. A nucleotide-dependent oligomerization of the Escherichia coli replication initiator DnaA requires residue His136 for remodeling of the chromosomal origin
  4. Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy
  5. Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma
  6. Repurposing of Carbapenems for the Treatment of Drug-Resistant Tuberculosis
  7. Mechanism based drug discovery against Mycobacterium abscessus by targeting L,D-transpeptidases
  8. LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems
  9. Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem
  10. Carbapenem drug resistance mechanism in Mycobacterium tuberculosis
  11. Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase
  12. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T224
  13. Development of new antibiotics for treatment of drug resistant Tuberculosis
  14. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T208
  15. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T210
  16. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T206 in conformation A
  17. Role of a non-canonical surface of Rad6 in ubiquitin conjugating activity
  18. Structure of the yeast Bre1 RING domain
  19. The crystal structure reveals the molecular mechanism of bifunctional 3,4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrolase II (Rv1415) fromMycobacterium tuberculosis
  20. Corrigendum to “Structural basis for pH dependent monomer–dimer transition of 3,4-dihydroxy 2-butanone-4-phosphate synthase domain from Mycobacterium tuberculosis” [J. Struct. Biol. 174 (2011) 374–384]
  21. Structural basis for pH dependent monomer–dimer transition of 3,4-dihydroxy 2-butanone-4-phosphate synthase domain from Mycobacterium tuberculosis
  22. Crystal structure analysis of icosahedral lumazine synthase fromSalmonella typhimurium, an antibacterial drug target
  23. Potential anti-bacterial drug target: Structural characterization of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Salmonella typhimurium LT2